TheProfitWatch

MRUS - Merus N.V. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
95.94 -0.16 (-0.17%) 0.0 (0.0%) 0.01 (0.01%) 0.01 (0.01%) 0.0 (0.0%) -0.13 (-0.13%) --- 0.0 (0.0%)

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-2.23
Diluted EPS:
-2.23
Basic P/E:
-42.9484
Diluted P/E:
-42.9484
RSI(14) 1m:
47.61
VWAP:
95.78
RVol:

Events

Period Kind Movement Occurred At

Related News